Vaxcyte Inc. Common Stock vs Silicon Motion Technology Corporation American Depositary Shares — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Silicon Motion Technology Corporation American Depositary Shares trades at $220.06 (market cap $8.36B). The key difference: Vaxcyte Inc. Common Stock is the larger of the two by market cap, and Silicon Motion Technology Corporation American Depositary Shares pays a 0.81% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Silicon Motion Technology Corporation American Depositary Shares for 0 Days on average.
| PCVX | SIMO | |
|---|---|---|
Market Cap | $10.51B | $8.36B |
Volume | 2,644,694 | 663,682 |
Sector | Health | Technology |
52-Week High | $73.82 | $336.90 |
52-Week Low | $40.32 | $80.16 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $8.35B |
Dividend Yield | — | 0.81% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Silicon Motion (SIMO) trades at $246.63, down 0.13% on the day, with technical indicators showing neutral signals. The company demonstrates strong fundamentals with Q2 2026 EPS beating expectations at $2.43 versus $2.13, and revenue growth projected to reach $1.3B in 2026. Analyst sentiment remains overwhelmingly positive with 81% buy ratings and a consensus price target of $356.25, representing 44% upside potential from current levels.
The outlook for SIMO appears favorable given accelerating enterprise storage demand and AI infrastructure expansion. Key risks include semiconductor cycle volatility and competitive pressures in NAND controllers. With robust profitability metrics including 31.6% ROE and expanding margins, the stock offers growth exposure to the AI storage market, though investors should monitor execution on Q3 2026 earnings expectations of $3.3 EPS.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Silicon Motion Technology Corporation designs and develops NAND flash controllers for solid-state storage, with flagship SSD, eMMC, and UFS controller products, including its Ferri-branded automotive and industrial storage solutions, used by OEMs and NAND flash makers worldwide.
Read more on SIMO →